KS
Kuruppath Sujatha
About Kuruppath Sujatha
Data last updated:
Kuruppath Sujatha has 12 years in corporate governance. Holds Whole-Time Director role. Currently with 1 company, including Geekay Speciality Chemicals (India) Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Geekay Speciality Chemicals (India) Private Limited at ₹4.94 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 13 Jan 2014 | 2014 | ₹4.94 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kuruppath Sujatha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kuruppath Sujatha
Kuruppath Sujatha has 12 years in corporate governance. Holds Whole-Time Director role. Currently with 1 company, including Geekay Speciality Chemicals (India) Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Geekay Speciality Chemicals (India) Private Limited at ₹4.94 Cr (FY 2024).
Kuruppath Sujatha is associated with 1 company as Whole-Time Director, including Geekay Speciality Chemicals (India) Private Limited (₹4.94 Cr).
Kuruppath Sujatha has expertise in General Business.
Kuruppath Sujatha has 12 years in corporate governance.
By reported revenue, the largest current company of Kuruppath Sujatha is Geekay Speciality Chemicals (India) Private Limited, with revenue of ₹4.94 Cr (FY 2024).
Kuruppath Sujatha currently holds positions at 1 company: Geekay Speciality Chemicals (India) Private Limited (₹4.94 Cr).